首页> 美国卫生研究院文献>AIDS Research and Human Retroviruses >Genotypic Variability of HIV-1 Reverse Transcriptase Gene from Long-Term Antiretroviral-Experienced Patients in Kenya
【2h】

Genotypic Variability of HIV-1 Reverse Transcriptase Gene from Long-Term Antiretroviral-Experienced Patients in Kenya

机译:肯尼亚长期接受抗逆转录病毒治疗的患者中HIV-1逆转录酶基因的基因型变异性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is continuous need to track genetic profiles of HIV strains circulating in different geographic settings to hasten vaccine discovery and inform public health and intervention policies. We partially sequenced the reverse transcriptase region of the HIV-1 pol gene from a total of 54 Kenyan patients aged 18–56 years who continued highly active antiretroviral treatment (HAART) for between 8 and 102 months. Subtyping was done using both the JPHMM tool and phylogenetic method. HIV-1 subtype A1 was the predominant strain in circulation, representing 57.4% and 70.4% of all isolates as determined by JPHMM and phylogenetic methods, respectively. Subtypes D (14.8%, 7.4%), C (5.6%, 9.3%), and A2 (0%, 5.6%) were determined at respective prevalence by both methods. JPHMM identified 22.2% of the isolates as recombinants. This surveillance focused on the RT gene and reaffirms the predominance of subtype A and an increasing proportion of recombinant strains in the Kenyan epidemic.
机译:持续需要追踪在不同地理环境中传播的HIV毒株的遗传概况,以加快疫苗的发现并告知公共卫生和干预政策。我们对来自54名肯尼亚患者的HIV-1 pol基因的逆转录酶区域进行了部分测序,这些患者年龄在18-56岁之间,接受了持续高活性的抗逆转录病毒治疗(HAART)8至102个月。使用JPHMM工具和系统发育方法进行了亚型分型。 HIV-1 A1亚型是循环中的主要毒株,分别通过JPHMM和系统发育方法测定,分别占所有分离株的57.4%和70.4%。通过这两种方法分别确定了D型(14.8%,7.4%),C(5.6%,9.3%)和A2(0%,5.6%)。 JPHMM确定了22.2%的分离株为重组体。这项监视的重点是RT基因,并重申了在肯尼亚流行病中A型亚型的优势和重组菌株比例的增加。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号